BioLargo Ownership

BLGO Stock  USD 0.25  0.01  3.85%   
BioLargo holds a total of 275.42 Million outstanding shares. BioLargo shows 14.7 percent of its outstanding shares held by insiders and 0.04 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in otc stocks such as BioLargo in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of BioLargo, and when they decide to sell, the otc stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLargo. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in price.

BioLargo OTC Stock Ownership Analysis

About 15.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.03. BioLargo last dividend was issued on the 28th of May 1997. The entity had 1:25 split on the 21st of March 2007. BioLargo, Inc. invents, develops, and commercializes various platform technologies. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California. Biolargo operates under Chemicals classification in the United States and is traded on OTC Exchange. It employs 31 people.The quote for BioLargo is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on BioLargo please contact Dennis Calvert at 888 400 2863 or go to https://www.biolargo.com.

BioLargo Outstanding Bonds

BioLargo issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. BioLargo uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most BioLargo bonds can be classified according to their maturity, which is the date when BioLargo has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Pair Trading with BioLargo

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioLargo position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLargo will appreciate offsetting losses from the drop in the long position's value.

Moving against BioLargo OTC Stock

  0.71PTAIF PT Astra InternationalPairCorr
  0.68CHKEW CHKEW Old Symbol ChangePairCorr
  0.61PCTTW PureCycle TechnologiesPairCorr
  0.5ADVWW Advantage SolutionsPairCorr
  0.46VLY Valley National BancorpPairCorr
The ability to find closely correlated positions to BioLargo could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioLargo when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioLargo - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioLargo to buy it.
The correlation of BioLargo is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioLargo moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioLargo moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioLargo can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in BioLargo OTC Stock

BioLargo financial ratios help investors to determine whether BioLargo OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioLargo with respect to the benefits of owning BioLargo security.